@article{fdi:010077108,
  title = {{D}evelopment of new {TB} regimens : harmonizing trial design, product registration requirements, and public health guidance},
  author = {{L}ienhardt, {C}hristian and {V}ernon, {A}. {A}. and {C}avaleri, {M}. and {N}ambiar, {S}. and {N}ahid, {P}.},
  editor = {},
  language = {{ENG}},
  abstract = {{C}hristian {L}ienhardt and colleagues discuss the importance of communication and coordination between regulators, researchers, and policy makers to ensure tuberculosis trials provide high-quality evidence for policy decisions.},
  keywords = {{MONDE}},
  booktitle = {},
  journal = {{PL}o{S} {M}edicine},
  volume = {16},
  numero = {9},
  pages = {e1002915 [13 p.]},
  ISSN = {1549-1277},
  year = {2019},
  DOI = {10.1371/journal.pmed.1002915},
  URL = {https://www.documentation.ird.fr/hor/fdi:010077108},
}